COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB COMPARED TO CURRENT BIOLOGICS SEQUENCES FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN FRANCE

被引：0
|
作者：
Duteil, E. [1 ]
Cariou, C. [1 ]
Schmidt, A. [2 ]
Benjamin, K. [1 ]
Duco, J. [1 ]
机构：
[1] Novartis Pharmaceut, Rueil Malmaison, France
[2] Steve Consultants, Oullins, France
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1395
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY80
引用
收藏
页码：A589 / A589
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness modelling of biological treatment sequences in moderate to severe rheumatoid arthritis in France
    Saraux, Alain
    Gossec, Laure
    Goupille, Philippe
    Bregman, Bruno
    Boccard, Eric
    Dupont, Danielle
    Beresniak, Ariel
    [J]. RHEUMATOLOGY, 2010, 49 (04) : 733 - 740
  • [32] COST-EFFECTIVENESS OF APREMILAST FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Maniadakis, N.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A803 - A803
  • [33] Cost-Effectiveness of Biological Therapy in Remission Induction of Moderate to Severe Plaque Psoriasis
    Schmitt-Rau, K.
    Rosenbach, T.
    Radtke, M. A.
    Augustin, M.
    [J]. DERMATOLOGY, 2010, 221 (03) : 236 - 242
  • [34] COST-EFFECTIVENESS OF USTEKINUMAB IN THE MANAGEMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN MEXICO
    Valencia-Mendoza, A.
    Hernandez-Garduno, A.
    Puig, A.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A513 - A514
  • [35] Cost-effectiveness of apremilast in moderate-to-severe chronic plaque psoriasis: a model analysis in the UK
    Mughal, F.
    Barker, J.
    Cawston, H.
    Damera, V.
    Bewley, A.
    Morris, J.
    Shaw, T.
    Tencer, T.
    Zhang, F.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 : 74 - 74
  • [36] The role of biologics in the treatment of moderate-to-severe plaque psoriasis
    Puig, Lluis
    [J]. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (01): : 28 - 35
  • [37] COST-EFFECTIVENESS OF SEQUENCES OF BIOLOGIC TREATMENTS FOR MODERATE-TO-SEVERE PSORIASIS IN FINLAND
    Asseburg, C.
    Valgardsson, S.
    Soini, E. J.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A507 - A508
  • [38] Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis
    de Miguel, Rebeca
    el-Azhary, Rokea
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (06) : 653 - 658
  • [39] Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis
    Pinter, A.
    Gerdes, S.
    Hacker, E.
    Reinhardt, M.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 114 - 115
  • [40] Cost-effectiveness analysis of amevivetm (Alefacept) in the treatment of patients with moderate-to-severe psoriasis
    Iskedjian, M
    Barkovsky, L
    Desjardins, O
    Walker, JH
    Dorkalam, M
    Shear, N
    Einarson, TR
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 330 - 330
12345